Tryptanthrin inhibits tumor angiogenesis via Notch/Dll4 signaling pathway in zebrafish
Translational Cancer Research · 2023-10 · 12 (10) · 2660-2672
DOI: 10.21037/tcr-23-925 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Cancer Research, 2023-10. Verfasst von Meimei Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Fuqing City Hospital Affiliated to Fujian Medical University, Fuzhou, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Fuqing City Hospital Affiliated to Fujian Medical University, Fuzhou, China.
- Department of Pharmacy, Affiliated Fuzhou First Hospital of Fujian Medical University, Fuzhou, China.
- Department of Endocrinology, Fuqing City Hospital Affiliated to Fujian Medical University, Fuzhou, China.
Zitieren
APA
Lin, M., Dai, H., Zheng, L., Yu, P., Chen, Y., Hong, R., & Zheng, C. (2023). Tryptanthrin inhibits tumor angiogenesis via Notch/Dll4 signaling pathway in zebrafish. Translational Cancer Research, 12(10), 2660-2672. https://doi.org/10.21037/tcr-23-925
Vancouver
Lin M, Dai H, Zheng L, Yu P, Chen Y, Hong R, et al. Tryptanthrin inhibits tumor angiogenesis via Notch/Dll4 signaling pathway in zebrafish. Translational Cancer Research. 2023;12(10):2660-2672. doi:10.21037/tcr-23-925
BibTeX
@article{Lin2023,
author = {Lin, Meimei and Dai, Hengfen and Zheng, Lanlan and Yu, Peiqing and Chen, Yan and Hong, Ru and Zheng, Caiyun},
title = {Tryptanthrin inhibits tumor angiogenesis via Notch/Dll4 signaling pathway in zebrafish},
journal = {Translational Cancer Research},
year = {2023},
volume = {12},
number = {10},
pages = {2660--2672},
doi = {10.21037/tcr-23-925}
}
EUVIMED